Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Nearly one third of adults worldwide failing to meet physical activity recommendations

New data show that nearly one third (31%) of adults worldwide, approximately 1.8 billion people, did not meet the recommended levels of physical activity in 2022.

26 Jun 2024

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Researchers compare the effectiveness of anti-diabetes medications in reducing the risk of dementia in older diabetics.

26 Jun 2024

Higher intake of ultra-processed foods found to increase cancer mortality risk

The association between ultra-processed food (UPF) consumption and gastrointestinal (GI) cancers.

26 Jun 2024

Dietary fiber promotes beneficial conversion of tryptophan by gut bacteria

We get healthy dietary fibres from consuming fruits, vegetables, and whole grains. But why are the fibres so good for us? A team of researchers has discovered that dietary fibres play a crucial role in determining the balance between the production of healthy and harmful substances by influencing the behavior of bacteria in the colon.

26 Jun 2024

Study offers insights into gut microbiome diversity and type 2 diabetes risk

Brigham, Broad and Harvard Chan School researchers found that specific species and strains of bacteria were linked to changes in the functioning of the gut microbiome and a person's risk of type 2 diabetes.

26 Jun 2024

Study provides resource for investigating diabetes-linked transcription factors

Scientists have generated a comprehensive map of the gene targets regulated by the transcription factors HNF4A and HNF1A in human pancreatic beta cells and liver cells. Published in the journal Nature Communications, the study revealed common and tissue-specific molecular pathways regulated by HNF4A and HNF1A, two proteins that possess important functions governing the development and function of the pancreas and liver.

26 Jun 2024

Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

Studies of mouse models of Fragile X syndrome and Phelan-McDermid syndrome show that treatment with cannabidiol (CBD) and the diabetes drug metformin can alleviate behavioral difficulties, according to research presented today (Wednesday) at the Federation of European Neuroscience Societies (FENS) Forum 2024.

26 Jun 2024

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

The SELECT trial found that semaglutide significantly reduces cardiovascular events in individuals with overweight or obesity and preexisting cardiovascular disease, regardless of baseline HbA1c or changes in HbA1c levels.

26 Jun 2024

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

The FLOW trial demonstrated that semaglutide significantly improves kidney and cardiovascular outcomes in people with chronic kidney disease and type 2 diabetes, irrespective of SGLT2 inhibitor use.

25 Jun 2024

Study reveals brain health benefits of intermittent fasting and healthy diet plans

Researchers from Johns Hopkins Medicine and the National Institutes of Health's National Institute on Aging say their study of 40 older adults with obesity and insulin resistance who were randomly assigned to either an intermittent fasting diet or a standard healthy diet approved by the U.S. Department of Agriculture (USDA) offers important clues about the potential benefits of both eating plans on brain health.

25 Jun 2024

Genetic variation in people of African ancestry linked to increased risk of diabetes complications

A genetic variation common in people of African ancestry is associated with an increased risk of complications from diabetes, including diabetic retinopathy, according to a report published June 25 in the journal Nature Medicine.

25 Jun 2024

MicroRNAs shed light on aggressive youthful type 2 diabetes

Type 2 diabetes in young people ages 10 to19 has more than doubled in the past 20 years, yet it remains difficult for physicians to predict who will be diagnosed and who will improve with treatment. A newly published study from the University of Oklahoma shows that measuring the circulating abundance of microRNAs – which affect insulin-producing beta cells in the pancreas – is likely as effective as measuring the level of sugar in the blood for determining how a young person with the condition will fare.

25 Jun 2024

Scientists discover link between birthweight and risk of health complications from childhood obesity

Scientists at the University of Copenhagen discover a link between birthweight and the risk of health complications from obesity during childhood.

24 Jun 2024

Semaglutide provides double benefit for women with heart failure

Semaglutide, a medication initially developed for type 2 diabetes and obesity, significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options.

24 Jun 2024

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Study shows that a 5:2 intermittent fasting meal replacement diet effectively controls blood glucose levels and reduces body weight in Chinese adults with early type 2 diabetes. This dietary intervention outperforms metformin and empagliflozin in managing diabetes and obesity.

24 Jun 2024

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Novo Nordisk today announced the presentation of 34 abstracts highlighting the breadth of its portfolio at the upcoming 84th Scientific Sessions of the American Diabetes Association (ADA).

22 Jun 2024

Nutritious diet may protect against type 2 diabetes, regardless of genetics

A healthy diet that adheres to nutrition recommendations is associated with better blood glucose levels and a lower risk of prediabetes and type 2 diabetes, a new study from the University of Eastern Finland shows. This association was observed also in individuals with a high genetic predisposition to type 2 diabetes.

22 Jun 2024

Tirzepatide emerges as first drug therapy for obstructive sleep apnea

Researchers at University of California San Diego School of Medicine and international collaborators have led a worldwide, advanced study demonstrating the potential of tirzepatide, known to manage type 2 diabetes, as the first effective drug therapy for obstructive sleep apnea (OSA), a sleep-related disorder characterized by repeated episodes of irregular breathing due to complete or partial blockage of the upper airway.

21 Jun 2024

Semaglutide weight loss results linked to diabetes severity

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

21 Jun 2024

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

People with type 2 diabetes who are treated with GLP-1 agonists have a decreased risk of developing dementia, according to a new study from Karolinska Institutet in Sweden published in the journal eClinicalMedicine.

20 Jun 2024

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Nearly one third of adults worldwide failing to meet physical activity recommendations

Differences in effectiveness among antihyperglycemic drugs on dementia risk identified in recent study

Higher intake of ultra-processed foods found to increase cancer mortality risk

Dietary fiber promotes beneficial conversion of tryptophan by gut bacteria

Study offers insights into gut microbiome diversity and type 2 diabetes risk

Study provides resource for investigating diabetes-linked transcription factors

Mouse models inform potential treatments for Fragile X, Phelan-McDermid syndromes

Semaglutide reduces heart risks in overweight and obese individuals without diabetes

Semaglutide proves a game-changer for kidney and heart health in diabetes patients

Study reveals brain health benefits of intermittent fasting and healthy diet plans

Genetic variation in people of African ancestry linked to increased risk of diabetes complications

MicroRNAs shed light on aggressive youthful type 2 diabetes

Scientists discover link between birthweight and risk of health complications from childhood obesity

Semaglutide provides double benefit for women with heart failure

Intermittent fasting outperforms traditional drugs in managing early type 2 diabetes

Novo Nordisk presents key findings from semaglutide trials at ADA scientific sessions 2024

Nutritious diet may protect against type 2 diabetes, regardless of genetics

Tirzepatide emerges as first drug therapy for obstructive sleep apnea

Semaglutide weight loss results linked to diabetes severity

GLP-1 agonists linked to reduced dementia risk in type 2 diabetes patients

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Type 2 Diabetes News and Research

Latest Type 2 Diabetes News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in